Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+46.0%
5Y CAGR+50.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+46.0%/yr
Annual compound
5Y CAGR
+50.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.8x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$321.01M+37.8%
2024$232.90M+94.6%
2023$119.69M+16.1%
2022$103.08M+96.0%
2021$52.58M+27.0%
2020$41.40M+29.9%
2019$31.88M+190.4%
2018$-35.26M-90.7%
2017$-18.49M-2.6%
2016$-18.03M-